[go: up one dir, main page]

WO2011087995A3 - Composés organiques - Google Patents

Composés organiques Download PDF

Info

Publication number
WO2011087995A3
WO2011087995A3 PCT/US2011/020724 US2011020724W WO2011087995A3 WO 2011087995 A3 WO2011087995 A3 WO 2011087995A3 US 2011020724 W US2011020724 W US 2011020724W WO 2011087995 A3 WO2011087995 A3 WO 2011087995A3
Authority
WO
WIPO (PCT)
Prior art keywords
mycobacterium
treatment
mycobacterial infections
imidazo
trypanosoma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2011/020724
Other languages
English (en)
Other versions
WO2011087995A2 (fr
Inventor
Clifton Barry
Joseph Cherian
Inhee Choi
Thomas Keller
Ujjini Manjunatha
Amit Nayyar
Hwan Ha Young
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2011087995A2 publication Critical patent/WO2011087995A2/fr
Anticipated expiration legal-status Critical
Publication of WO2011087995A3 publication Critical patent/WO2011087995A3/fr
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/06—Antibacterial agents for tuberculosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des composés qui sont utiles dans le traitement d'infections mycobactériennes, des compositions pharmaceutiques contenant les composés, des procédés pour leur préparation, et des utilisations des composés dans différentes applications médicales, telles que le traitement ou la prévention d'infections mycobactériennes, telles que celles causées par Mycobacterium tuberculosis, Mycobacterium bovis, Mycobacterium leprae, Mycobacterium africanum, Mycobacterium avium, Mycobacterium microti, ou toute mycobactérie qui entraine une tuberculose multirésistante aux médicaments (MDR) ou une tuberculose extrêmement résistante (XDR), ou toute autre espèce mycobactérienne connue pour entraîner la maladie chez les humains; ou le traitement ou la prévention de maladies parasitaires, telles que celles causées par un parasite du genre Trypanosoma, par exemple, Trypanosoma cruzi ou Trypanosoma brucei ou un parasite du genre Leishmania qui entraîne une leishmaniose viscérale ou le kala-azar, par exemple, Leishmania donovani.
PCT/US2011/020724 2010-01-13 2011-01-11 Composés organiques Ceased WO2011087995A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29463410P 2010-01-13 2010-01-13
US61/294,634 2010-01-13

Publications (2)

Publication Number Publication Date
WO2011087995A2 WO2011087995A2 (fr) 2011-07-21
WO2011087995A3 true WO2011087995A3 (fr) 2013-03-21

Family

ID=44304922

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2011/020724 Ceased WO2011087995A2 (fr) 2010-01-13 2011-01-11 Composés organiques

Country Status (1)

Country Link
WO (1) WO2011087995A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10227362B2 (en) 2015-01-29 2019-03-12 Medshine Discovery Inc. Anti-pulmonary tuberculosis nitroimidazole derivative

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104059082B (zh) * 2013-03-21 2016-08-03 苏州迈泰生物技术有限公司 硝基咪唑杂环类化合物及其在制备治疗结核病药物中的应用
KR101682356B1 (ko) * 2014-11-04 2016-12-06 한국화학연구원 이미다조 옥사진 유도체, 이의 약학적으로 허용 가능한 염 또는 이의 광학이성질체 및 이를 유효성분으로 함유하는 약제학적 조성물
CN105732659B (zh) * 2014-12-12 2019-07-16 上海阳帆医药科技有限公司 硝基咪唑类化合物及其制备方法和在制药中的用途

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087358A (en) * 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
WO2007075872A2 (fr) * 2005-12-23 2007-07-05 Novartis Ag Composes de nitroimidazole

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087358A (en) * 1995-06-26 2000-07-11 Pathogenesis Corporation Nitro-[2,1-b]imidazopyran compounds and antibacterial uses thereof
WO2007075872A2 (fr) * 2005-12-23 2007-07-05 Novartis Ag Composes de nitroimidazole

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
LI ET AL: "Synthesis and antitubercular activity of 7-(R)- and 7-(S)-methyl-2-nitro-6-(S)-(4-(trifluoromethoxy)benzyloxy)-6,7-dihydro-5H-imidazo[2,1-b][1,3]oxazines, analogues of PA-824", BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, PERGAMON, ELSEVIER SCIENCE, GB, vol. 18, no. 7, 7 March 2008 (2008-03-07), pages 2256 - 2262, XP022574941, ISSN: 0960-894X, DOI: 10.1016/J.BMCL.2008.03.011 *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10227362B2 (en) 2015-01-29 2019-03-12 Medshine Discovery Inc. Anti-pulmonary tuberculosis nitroimidazole derivative

Also Published As

Publication number Publication date
WO2011087995A2 (fr) 2011-07-21

Similar Documents

Publication Publication Date Title
PH12016502581A1 (en) TrK-INHIBITING COMPOUND
WO2015021382A3 (fr) Compositions topiques et procédés d'utilisation de celles-ci
UY29608A1 (es) Compuestos quimicos
BRPI0820162A2 (pt) composto, composição farmacêutica, método para a profilazia ou tratamento de infecção pela hiv ou para a profilaxia, tratamento ou retardo no início da aids
WO2011087995A3 (fr) Composés organiques
BRPI0911577B8 (pt) derivados espiro-indol, seus usos no tratamento de doenças parasíticas, e composição farmacêutica
IN2015DN02966A (fr)
WO2019035705A3 (fr) Composition topique semi-solide contenant un agent antimicrobien et de la pirfénidone pour le traitement d'affections chroniques de la peau
BR112015004843A2 (pt) uso de uma combinação de pelo menos dois compostos selecionados de baclofeno, acamprosato, cinacalcet, mexiletina, sulfisoxazol e torasemida, ou sal(ais), pró-fármaco(s), derivado(s) ou formulação(ões) com liberação sustentada dos mesmos
WO2008146172A3 (fr) Composés présentant une activité antiparasitaire, leurs applications au traitement de maladies infectieuses provoquées par des apicomplexans
WO2007075872A3 (fr) Composes de nitroimidazole
WO2014064652A3 (fr) Composition pharmaceutique stable d'interféron pégylé alpha-2b
WO2017158616A8 (fr) Composés de carbapénème
BRPI0821909A2 (pt) derivado de piperidina
EA200800455A1 (ru) Антибактериальные производные хинолина
WO2013056003A3 (fr) Diéthers de catéchol comme agents anti-hiv puissants
UY36469A (es) Nuevo compuesto de tiotriazol
WO2008024753A3 (fr) Nanoparticules dérivées de lipide pour administration de médicament dans le cerveau
PH12016501215A1 (en) Azaindole derivative
WO2011021230A3 (fr) Nouveau complexe pour le traitement et/ou la prophylaxie d'infections parasitaires
BRPI0517646A (pt) compostos de aril pirimidila, composições farmacêuticas compreendendo os mesmos, seu uso como agentes antimicrobianos
BR112015023560A2 (pt) novos derivados de acrilamida como agentes antimaláricos
WO2013151597A3 (fr) Dérivés de (1,2,3-triazolyl)sulfonyle
EP3636642A8 (fr) Dérivé d'acide indolacétique, son procédé de préparation et son utilisation pharmaceutique
WO2012095500A3 (fr) Compositions pharmaceutiques pour le traitement de maladies parasitaires, d'un cancer ou de maladies de la peau par administration topique

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11733239

Country of ref document: EP

Kind code of ref document: A2